ROSALEEN GALVIN: Open Payments
NPI 1457961062 · FAIRFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 25 payments from 16 companies in 2025. Trend: 2023 $979 · 2024 $1,165 · 2025 $952
Food & beverage: $749Education: $204
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $203 |
| Agios Pharmaceuticals, Inc. | 2 | $148 |
| Novartis Pharmaceuticals Corporation | 4 | $106 |
| Astellas Pharma US Inc | 1 | $100 |
| Amgen Inc. | 1 | $58 |
| ARRAY BIOPHARMA INC | 3 | $49 |
| ABBVIE INC. | 2 | $46 |
| PFIZER INC. | 2 | $41 |
| Eisai Inc. | 1 | $31 |
| Rigel Pharmaceuticals, Inc. | 1 | $29 |
Products named: PYRUKYND, RYBREVANT, Fabhalta, DARZALEX, LORBRENA, BLINCYTO, IMBRUVICA, OPDIVO.
Industry payments across CT — which companies pay providers there.
